Percutaneous coronary invervention versus coronary artery bypass grafting: A meta-Analysis

Journal of Thoracic and Cardiovascular Surgery

Volumn 149, Issue 3, 2015, Pages 831-838.e13

  Smit, Yolba ^a   Vlayen, Joan ^b   Koppenaal, Hetty ^c   Eefting, Frank ^d   Kappetein, Arie Pieter ^e   Mariani, Massimo A ^f  

^a Independent Researcher   (Netherlands)

^b ME TA   (Belgium)

^c Independent researcher   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARE METAL STENT; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; COCHRANE LIBRARY; COMPARATIVE EFFECTIVENESS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; CORONARY STENTING; DETERIORATION; DEVICE THERAPY; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING CORONARY STENT; EMBASE; FOLLOW UP; HEART INFARCTION; HUMAN; MEDLINE; META ANALYSIS; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REOPERATION; SURGICAL PATIENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VASCULAR DISEASE; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; DEVICES; MORTALITY; MYOCARDIAL INFARCTION; ODDS RATIO; PROSTHESIS DESIGN; RISK FACTOR; STENT; STROKE; TIME FACTOR;

CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; HUMANS; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RISK FACTORS; STENTS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84926050433     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.10.112     Document Type: Article

References (120)

1. A. Bakhai, R.A. Hill, Y. Dundar, R. Dickson, and T. Walley Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes Cochrane Database Syst Rev 2005 CD004588
2. S.J. Pocock, R.A. Henderson, A.F. Rickards, J.R. Hampton, S.B. King III, and C.W. Hamm Meta-Analysis of randomised trials comparing coronary angioplasty with bypass surgery Lancet 346 1995 1184 1189
3. D.M. Bravata, A.L. Gienger, K.M. McDonald, V. Sundaram, M.V. Perez, and R. Varghese Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery Ann Intern Med 147 2007 703 716
4. O. Aziz, C. Rao, S.S. Panesar, C. Jones, S. Morris, and A. Darzi Meta-Analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery BMJ 334 2007 617
5. Z. Jaffery, M. Kowalski, W.D. Weaver, and S. Khanal A meta-Analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery Eur J Cardiothorac Surg 31 2007 691 697
6. M. Boodhwani, F.D. Rubens, F.W. Sellke, T.G. Mesana, and M. Ruel Mortality and myocardial infarction following surgical versus percutaneous revascularization of isolated left anterior descending artery disease: a meta-Analysis Eur J Cardiothorac Surg 29 2006 65 70
7. C. Rao, O. Aziz, S.S. Panesar, C. Jones, S. Morris, and A. Darzi Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery BMJ 334 2007 621
8. Y. Onuma, J. Daemen, N. Kukreja, and P. Serruys Revascularization in the high-risk patient: multivessel disease Minerva Cardioangiol 55 2007 579 592
9. S. Desch, E. Boudriot, A. Rastan, P.E. Buszman, A. Bochenek, and F.W. Mohr Bypass surgery versus percutaneous coronary intervention for the treatment of unprotected left main disease. A meta-Analysis of randomized controlled trials Herz 38 2013 48 56
10. I. Sipahi, M.H. Akay, S. Dagdelen, A. Blitz, and C. Alhan Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-Analysis of randomized clinical trials of the arterial grafting and stenting era JAMA Intern Med 174 2014 223 230
11. D. Bainbridge, D. Cheng, J. Martin, and R. Novick Does off-pump or minimally invasive coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with percutaneous coronary intervention' A meta-Analysis of randomized trials J Thorac Cardiovasc Surg 133 2007 623 631
12. A. Hakeem, N. Garg, S. Bhatti, N. Rajpurohit, Z. Ahmed, and B.F. Uretsky Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-Analysis of randomized clinical data J Am Heart Assoc 2 2013 e000354
13. N. Mercado, W. Wijns, P.W. Serruys, U. Sigwart, M.D. Flather, and R.H. Stables One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-Analysis of individual patient data from randomized clinical trials J Thorac Cardiovasc Surg 130 2005 512 519
14. J. Daemen, E. Boersma, M. Flather, J. Booth, R. Stables, and A. Rodriguez Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-Analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials Circulation 118 2008 1146 1154
15. M.A. Hlatky, D.B. Boothroyd, D.M. Bravata, E. Boersma, J. Booth, and M.M. Brooks Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials Lancet 373 2009 1190 1197
16. K.F. Schulz, I. Chalmers, R.J. Hayes, and D.G. Altman Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials JAMA 273 1995 408 412
17. E.V. Villanueva, J. Wasiak, and E.S. Petherick Percutaneous transluminal rotational atherectomy for coronary artery disease Cochrane Database Syst Rev 2003 CD003334
18. J.P. Ioannidis, N.A. Patsopoulos, and E. Evangelou Uncertainty in heterogeneity estimates in meta-Analyses BMJ 335 2007 914 916
19. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-Analysis Stat Med 21 2002 1539 1558
20. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators N Engl J Med 335 1996 217 225
21. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators JAMA 277 1997 715 721
22. BARI Investigators Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status J Am Coll Cardiol 35 2000 1122 1129
23. BARI Investigators The final 10-year follow-up results from the BARI randomized trial J Am Coll Cardiol 49 2007 1600 1606
24. M.G. Bourassa, G.S. Roubin, K.M. Detre, G. Sopko, R.J. Krone, and M.J. Attabuto Bypass Angioplasty Revascularization Investigation: patient screening, selection, and recruitment Am J Cardiol 75 1995 3C 8C
25. M.M. Brooks, R.H. Jones, R.G. Bach, B.R. Chaitman, M.J. Kern, and T.A. Orszulak Predictors of mortality and mortality from cardiac causes in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and registry. For the BARI Investigators Circulation 101 2000 2682 2689
26. B.R. Chaitman, A.D. Rosen, D.O. Williams, M.G. Bourassa, F.V. Aguirre, and B. Pitt Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial Circulation 96 1997 2162 2170
27. C.J. Mullany, M.B. Mock, M.M. Brooks, S.F. Kelsey, N.M. Keller, and K. Sutton-Tyrrell Effect of age in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial Ann Thorac Surg 67 1999 396 403
28. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) Circulation 96 1997 1761 1769
29. A.S. Kurbaan, T.J. Bowker, and A.F. Rickards Trials of angioplasty and surgery: CABRI Semin Interv Cardiol 4 1999 179 184
30. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants Lancet 346 1995 1179 1184
31. A.S. Kurbaan, T.J. Bowker, C.D. Ilsley, U. Sigwart, and A.F. Rickards Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode Am J Cardiol 87 2001 947 950
32. A.S. Kurbaan, T.J. Bowker, C.D. Ilsley, R.A. Foale, U. Sigwart, and A.F. Rickards The effect of adjusting for baseline risk factors and post revascularisation coronary disease on comparisons between coronary angioplasty and bypass surgery Int J Cardiol 77 2001 207 214
33. S.B. King III, A.S. Kosinski, R.A. Guyton, N.J. Lembo, and W.S. Weintraub Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST) J Am Coll Cardiol 35 2000 1116 1121
34. S.B. King III, H.X. Barnhart, A.S. Kosinski, W.S. Weintraub, N.J. Lembo, and J.Y. Petersen Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators Am J Cardiol 79 1997 1453 1459
35. S.B. King III, N.J. Lembo, W.S. Weintraub, A.S. Kosinski, H.X. Barnhart, and M.H. Kutner A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST) N Engl J Med 331 1994 1044 1050
36. S.B. King III The Emory Angioplasty vs Surgery Trial (EAST) Semin Interv Cardiol 4 1999 185 190
37. A. Rodriguez, F. Boullon, N. Perez-Balino, C. Paviotti, M.I. Liprandi, and I.F. Palacios Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group J Am Coll Cardiol 22 1993 1060 1067
38. A. Rodriguez, E. Mele, E. Peyregne, F. Bullon, N. Perez-Balino, and M.I. Liprandi Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI) J Am Coll Cardiol 27 1996 1178 1184
39. D. Carrie, M. Elbaz, J. Puel, J. Fourcade, E. Karouny, and G. Fournial Five-year outcome after coronary angioplasty versus bypass surgery in multivessel coronary artery disease: results from the French Monocentric Study Circulation 96 9 Suppl 1997 II-1 II-6
40. J. Kaehler, R. Koester, W. Billmann, C. Schroeder, H.J. Rupprecht, and T. Ischinger 13-year follow-up of the German Angioplasty Bypass Surgery Investigation Eur Heart J 26 2005 2148 2153
41. C.W. Hamm, J. Reimers, T. Ischinger, H.J. Rupprecht, J. Berger, and W. Bleifeld A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) N Engl J Med 331 1994 1037 1043
42. J.J. Goy, E. Eeckhout, C. Moret, B. Burnand, P. Vogt, and J.C. Stauffer Five-year outcome in patients with isolated proximal left anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting. A prospective trial Circulation 99 1999 3255 3259
43. J.J. Goy, E. Eeckhout, B. Burnand, P. Vogt, J.C. Stauffer, and M. Hurni Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis Lancet 343 1994 1449 1453
44. W.A. Hueb, P.R. Soares, O.S. meida De, S. Arie, R.H. Cardoso, and D.B. Wajsbrot Five-year follow-op of the medicine, angioplasty, or surgery study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis Circulation 100 19 Suppl 1999 II107 II113
45. W.A. Hueb, G. Bellotti, S.A. de Oliveira, S. Arie, C.P. de Albuquerque, and A.D. Jatene The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses J Am Coll Cardiol 26 1995 1600 1605
46. J.R. Hampton Long-term results of RITA-1 Eur Heart J 20 1999 849 850
47. J.R. Hampton RITA Semin Interv Cardiol 4 1999 169 177
48. R.A. Henderson The Randomised Intervention Treatment of Angina (RITA) Trial protocol: a long term study of coronary angioplasty and coronary artery bypass surgery in patients with angina Br Heart J 62 1989 411 414
49. R.A. Henderson, S.J. Pocock, S.J. Sharp, K. Nanchahal, M.J. Sculpher, and M.J. Buxton Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-Artery bypass grafting. Randomised Intervention Treatment of Angina Lancet 352 1998 1419 1425
50. S.J. Pocock, R.A. Henderson, P. Seed, T. Treasure, and J.R. Hampton Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial Circulation 94 1996 135 142
51. B.C. Reeves, G.D. Angelini, A.J. Bryan, F.C. Taylor, T. Cripps, and T.J. Spyt A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery Health Technol Assess 8 2004 1 43
52. V.M. Legrand, P.W. Serruys, F. Unger, B.A. van Hout, M.C. Vrolix, and G.M. Fransen Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease Circulation 109 2004 1114 1120
53. F. Unger, P.W. Serruys, M.H. Yacoub, C. Ilsley, P.K. Paulsen, and T.T. Nielsen Revascularization in multivessel disease: comparison between two-year outcomes of coronary bypass surgery and stenting J Thorac Cardiovasc Surg 125 2003 809 820
54. P.W. Serruys, A.T. Ong, L.A. van Herwerden, J.E. Sousa, A. Jatene, and J.J. Bonnier Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial J Am Coll Cardiol 46 2005 575 581
55. P.W. Serruys, F. Unger, B.A. van Hout, M.J. van den Brand, L.A. van Herwerden, and G.A. van Es The ARTS study (Arterial Revascularization Therapies Study) Semin Interv Cardiol 4 1999 209 219
56. P.W. Serruys, F. Unger, J.E. Sousa, A. Jatene, H.J. Bonnier, and J.P. Schonberger Comparison of coronary-Artery bypass surgery and stenting for the treatment of multivessel disease N Engl J Med 344 2001 1117 1124
57. J. Aoki, A.T. Ong, C.A. Arampatzis, M. Vijaykumar, G.A. Rodriguez Granillo, and C.M. Disco Comparison of three-year outcomes after coronary stenting versus coronary artery bypass grafting in patients with multivessel coronary disease, including involvement of the left anterior descending coronary artery proximally (a subanalysis of the arterial revascularization therapies study trial) Am J Cardiol 94 2004 627 631
58. P.J. de Feyter, P.W. Serruys, F. Unger, R. Beyar, V. de Valk, and S. Milo Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina Circulation 105 2002 2367 2372
59. A. Abizaid, M.A. Costa, M. Centemero, A.S. Abizaid, V.M. Legrand, and R.V. Limet Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial Circulation 104 2001 533 538
60. M. Cisowski, J. Drzewiecki, A. Drzewiecka-Gerber, A. Jaklik, W. Kruczak, and M. Szczeklik Primary stenting versus MIDCAB: preliminary report-comparision of two methods of revascularization in single left anterior descending coronary artery stenosis Ann Thorac Surg 74 2002 S1334 S1339
61. M. Cisowski, A. Drzewiecka-Gerber, R. Ulczok, S.R. Abu, J. Drzewiecki, and M. Guzy Primary direct stenting versus endoscopic atraumatic coronary artery bypass surgery in patients with proximal stenosis of the left anterior descending coronary artery-A prospective, randomised study Kardiol Pol 61 2004 253 261
62. A. Diegeler, H. Thiele, V. Falk, R. Hambrecht, N. Spyrantis, and P. Sick Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery N Engl J Med 347 2002 561 566
63. S. Blazek, D. Holzhey, C. Jungert, M.A. Borger, G. Fuernau, and S. Desch Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 10-year follow-up of a randomized trial JACC Cardiovasc Interv 6 2013 20 26
64. H. Thiele, S. Oettel, S. Jacobs, R. Hambrecht, P. Sick, and J.F. Gummert Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: a 5-year follow-up Circulation 112 2005 3445 3450
65. D.J. Drenth, N.J. Veeger, J.G. Grandjean, M.A. Mariani, A.J. van Boven, and P.W. Boonstra Isolated high-grade lesion of the proximal LAD: a stent or off-pump LIMA' Eur J Cardiothorac Surg 25 2004 567 571
66. D.J. Drenth, N.J. Veeger, J.B. Winter, J.G. Grandjean, M.A. Mariani, and A.J. Boven van A prospective randomized trial comparing stenting with off-pump coronary surgery for high-grade stenosis in the proximal left anterior descending coronary artery: three-year follow-up J Am Coll Cardiol 40 2002 1955 1960
67. D.J. Drenth, J.B. Winter, N.J. Veeger, S.H. Monnink, A.J. van Boven, and J.G. Grandjean Minimally invasive coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty with stenting in isolated high-grade stenosis of the proximal left anterior descending coronary artery: six months' angiographic and clinical follow-up of a prospective randomized study J Thorac Cardiovasc Surg 124 2002 130 135
68. D.J. Drenth, N.J. Veeger, B. Middel, F. Zijlstra, and P.W. Boonstra Comparison of late (four years) functional health status between percutaneous transluminal angioplasty intervention and off-pump left internal mammary artery bypass grafting for isolated high-grade narrowing of the proximal left anterior descending coronary artery Am J Cardiol 94 2004 1414 1417
69. A. Rodriguez, V. Bernardi, J. Navia, J. Baldi, L. Grinfeld, and J. Martinez Argentine Randomized Study: Coronary Angioplasty With Stenting versus Coronary Bypass Surgery in Patients With Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators J Am Coll Cardiol 37 2001 51 58
70. A.E. Rodriguez, J. Baldi, P.C. Fernandez, J. Navia, A.M. Rodriguez, and A. Delacasa Five-year follow-up of the Argentine Randomized Trial of Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease (ERACI II) J Am Coll Cardiol 46 2005 582 588
71. L. Grip, P. Wahrborg, A. Odell, P. Albertsson, P. Berglin, and G. Brandrup-Wognsen Coronary artery bypass beating heart surgery with LIMA graft, versus coronary angioplasty with stent for patients with single left anterior descending artery-A pilot study Eur Heart J 22 Suppl 2001 597
72. J.W. Kim, D.S. Lim, K. Sun, W.J. Shim, and Y.M. Rho Stenting or MIDCAB using ministernotomy for revascularization of proximal left anterior descending artery' Int J Cardiol 99 2005 437 441
73. P.E. Buszman, S.R. Kiesz, A. Bochenek, E. Peszek-Przybyla, I. Szkrobka, and M. Debinski Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization J Am Coll Cardiol 51 2008 538 545
74. B.E. Pawel, and P.P. Buszman Late outcomes of unprotected left main stenting in comparison with surgical revascularization-ten-year clinical follow up of the LEMANS trial J Am Coll Cardiol 62 2013 B9
75. W. Hueb, N.H. Lopes, B.J. Gersh, P. Soares, L.A. Machado, and F.B. Jatene Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease Circulation 115 2007 1082 1089
76. W. Hueb, P.R. Soares, B.J. Gersh, L.A. Cesar, P.L. Luz, and L.B. Puig The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results J Am Coll Cardiol 43 2004 1743 1751
77. P.R. Soares, W.A. Hueb, P.A. Lemos, N. Lopes, E.E. Martinez, and L.A. Cesar Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II) Circulation 114 1 Suppl 2006 I420 I424
78. M.E. Favarato, W. Hueb, W.E. Boden, N. Lopes, C.R. Nogueira, and M. Takiuti Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial Int J Cardiol 116 2007 364 370
79. W. Hueb, N. Lopes, B.J. Gersh, P.R. Soares, E.E. Ribeiro, and A.C. Pereira Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease Circulation 122 2010 949 957
80. E.G. Lima, W. Hueb, R.M. Garcia, A.C. Pereira, P.R. Soares, and D. Favarato Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial Am Heart J 166 2013 250 257
81. T. Pohl, W. Giehrl, B. Reichart, C. Kupatt, P. Raake, and S. Paul Retroinfusion-supported stenting in high-risk patients for percutaneous intervention and bypass surgery: results of the prospective randomized myoprotect I study Catheter Cardiovasc Interv 62 2004 323 330
82. H.M. Nathoe, D. Van Dijk, E.W.L. Jansen, C. Borst, D.E. Grobbee, and P.P.T. De Jaegere Off-pump coronary artery bypass surgery compared with stent implantation and on-pump bypass surgery: clinical outcome and cost-effectiveness at one year Neth Heart J 13 2005 213 222
83. F. Eefting, H. Nathoe, D.D. van, E. Jansen, J. Lahpor, and P. Stella Randomized comparison between stenting and off-pump bypass surgery in patients referred for angioplasty Circulation 108 2003 2870 2876
84. H.M. Nathoe, J.J. Regieli, D. Van Dijk, P.R. Stella, J.R. Lahpor, and M.P. Buijsrogge Long-term clinical and angiographic outcome after stent-implantation versus off-pump coronary bypass surgery Eur Heart J 32 2011
85. J.J. Goy, U. Kaufmann, D. Goy-Eggenberger, A. Garachemani, M. Hurni, and T. Carrel A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery Mayo Clin Proc 75 2000 1116 1123
86. J.J. Goy, U. Kaufmann, M. Hurni, S. Cook, F. Versaci, and P. Ruchat 10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial J Am Coll Cardiol 52 2008 815 817
87. SoS Investigators Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial Lancet 360 2002 965 970
88. Z. Zhang, E.M. Mahoney, R.H. Stables, J. Booth, F. Nugara, and J.A. Spertus Disease-specific health status after stent-Assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial Circulation 108 2003 1694 1700
89. Z. Zhang, E.M. Mahoney, J.A. Spertus, J. Booth, F. Nugara, and P. Kolm The impact of age on outcomes after coronary artery bypass surgery versus stent-Assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial Am Heart J 152 2006 1153 1160
90. J. Booth, T. Clayton, J. Pepper, F. Nugara, M. Flather, and U. Sigwart Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS) Circulation 118 2008 381 388
91. E. Boudriot, H. Thiele, T. Walther, C. Liebetrau, P. Boeckstegers, and T. Pohl Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis J Am Coll Cardiol 57 2011 538 545
92. E. Boudriot, H. Thiele, F.J. Neumann, M. Gick, B. Reichard, and P. Boekstegers 5-year results of treatment of Unprotected Left Main Stenosis by CABG or PCI with Sirolimus eluting stent. A multicenter, randomized trial J Am Coll Cardiol 58 20 Suppl B 2011 B89
93. A. Kapur, R.J. Hall, I.S. Malik, A.C. Qureshi, J. Butts, and B.M. de Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial J Am Coll Cardiol 55 2010 432 440
94. M.E. Farkouh, M. Domanski, L.A. Sleeper, F.S. Siami, G. Dangas, and M. Mack Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
95. M.E. Farkouh, G. Dangas, M.B. Leon, C. Smith, R. Nesto, and J.B. Buse Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial Am Heart J 155 2008 215 223
96. M.S. Abdallah, K. Wang, E.A. Magnuson, J.A. Spertus, M.E. Farkouh, and V. Fuster Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial JAMA 310 2013 1581 1590
97. S.J. Hong, D.S. Lim, H.S. Seo, Y.H. Kim, W.J. Shim, and C.G. Park Percutaneous coronary intervention with drug-eluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis Catheter Cardiovasc Interv 64 2005 75 81
98. S.J. Park, Y.H. Kim, D.W. Park, S.C. Yun, J.M. Ahn, and H.G. Song Randomized trial of stents versus bypass surgery for left main coronary artery disease N Engl J Med 364 2011 1718 1727
99. P.W. Serruys, M.C. Morice, A.P. Kappetein, A. Colombo, D.R. Holmes, and M.J. Mack Percutaneous coronary intervention versus coronary-Artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
100. A.P. Kappetein, T.E. Feldman, M.J. Mack, M.C. Morice, D.R. Holmes, and E. Stahle Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 32 2011 2125 2134
101. M.J. Mack, A.P. Banning, P.W. Serruys, M.C. Morice, Y. Taeymans, and N.G. Van Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome Ann Thorac Surg 92 2011 2140 2146
102. A.P. Banning, S. Westaby, M.C. Morice, A.P. Kappetein, F.W. Mohr, and S. Berti Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents J Am Coll Cardiol 55 2010 1067 1075
103. F.W. Mohr, M.C. Morice, A.P. Kappetein, T.E. Feldman, E. Stahle, and M.J. Mack Final five-year follow-up of the SYNTAX trial: optimal revascularisation strategy in patients with three-vessel disease and/or left main disease Eur Heart J 33 2012 500
104. A.P. Kappetein, S.J. Head, M. Morice, A. Banning, P. Serruys, and F. Mohr Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of coronary artery bypass grafting and percutaneous coronary intervention in the syntax study Interact Cardiovasc Thorac Surg 15 2012 S74
105. A.P. Kappetein, S.J. Head, M.C. Morice, A.P. Banning, P.W. Serruys, and F.W. Mohr Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial Eur J Cardiothorac Surg 43 2013 1006 1013
106. M.J. Mack, S.J. Head, D.R. Holmes Jr., E. Stahle, T.E. Feldman, and A. Colombo Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease JACC Cardiovasc Interv 6 2013 344 354
107. V. Farooq, P.W. Serruys, C. Bourantas, P. Vranckx, R. Diletti, and H.M. Garcia Garcia Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial Eur Heart J 33 2012 3105 3113
108. F.W. Mohr, M.C. Morice, A.P. Kappetein, T.E. Feldman, E. Stahle, and A. Colombo Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial Lancet 381 2013 629 638
109. H. Thiele, P. Neumann-Schniedewind, S. Jacobs, E. Boudriot, T. Walther, and F.W. Mohr Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis J Am Coll Cardiol 53 2009 2324 2331
110. M. Kamalesh, T.G. Sharp, X.C. Tang, K. Shunk, H.B. Ward, and J. Walsh Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes J Am Coll Cardiol 61 2013 808 816
111. D.A. Morrison, G. Sethi, J. Sacks, W. Henderson, F. Grover, and S. Sedlis Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) J Am Coll Cardiol 38 2001 143 149
112. D.A. Morrison, G. Sethi, J. Sacks, F. Grover, S. Sedlis, and R. Esposito A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of the Department of Veterans Affairs Control Clin Trials 20 1999 601 619
113. K.T. Stroupe, D.A. Morrison, M.A. Hlatky, P.G. Barnett, L. Cao, and C. Lyttle Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients Circulation 114 2006 1251 1257
114. K.B. Ramanathan, D.S. Weiman, J. Sacks, D.A. Morrison, S. Sedlis, and G. Sethi Percutaneous intervention versus coronary bypass surgery for patients older than 70 years of age with high-risk unstable angina Ann Thorac Surg 80 2005 1340 1346
115. J.S. Rumsfeld, D.J. Magid, M.E. Plomondon, J. Sacks, W. Henderson, and M. Hlatky Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia J Am Coll Cardiol 41 2003 1732 1738
116. S.P. Sedlis, D.A. Morrison, J.D. Lorin, R. Esposito, G. Sethi, and J. Sacks Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry J Am Coll Cardiol 40 2002 1555 1566
117. S.P. Sedlis, K.B. Ramanathan, D.A. Morrison, G. Sethi, J. Sacks, and W. Henderson Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry) Am J Cardiol 94 2004 118 120
118. D. Capodanno, and C. Tamburino Unraveling the EXCEL: promises and challenges of the next trial of left main percutaneous coronary intervention Int J Cardiol 156 2012 1 3
119. B.C. Tong, J.C. Huber, D.D. Ascheim, J.D. Puskas, T.B. Ferguson Jr., and E.H. Blackstone Weighting composite endpoints in clinical trials: essential evidence for the heart team Ann Thorac Surg 94 2012 1908 1913
120. T. Palmerini, G. Biondi-Zoccai, D.D. Riva, A. Mariani, C. Savini, and E.M. Di Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: evidence from a comprehensive network meta-Analysis Am Heart J 165 2013 910 917